Invasive Group A Streptococcal Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-01

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to Infections

NCT02010294

Invasive GAS Infection

COMPLETED

Severe Group A Streptococcus Infections in Paris, France, 2018-2023

NCT06297122

Invasive Group A Beta-Haemolytic Streptococcal Disease

COMPLETED

Paediatric European Group A Streptococcal United Study.

NCT06058117

Invasive Group A Beta-Haemolytic Streptococcal Disease

RECRUITING

Group B Strep Correlates of Protection Study

NCT06431217

Maternal Health Child Health Infectious Diseases

COMPLETED

Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis

NCT01719510

Neonatal Infections Colonize With Group B Streptococci

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main of this study is to identify and record cases of invasive and severe infections due to Streptococcus pyogenes. In order to evaluate the incidence of severe forms of disease and the possible contributing factors, and to optimize their management.

Admitted patients to intensive care or critical care units in reported via Santé Publique France may also be included in this study.

Secondly, epidemiological, clinical, bacteriological data of all severe or not cases, of group A Streptococcal infections will be compiled to describe their characteristics, and try to explain this recrudescence as well as possible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Due to Streptococcus, Group A Risk Factors Severe Infection Medical Care Medical Complications Outcome, Fatal Therapy Strain Virulence Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\<18 years
* Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)